Challenges of Living with a Chronic Inflammatory Bowel Disease – Interview
Ulcerative colitis is a chronic, progressive inflammatory bowel disease that causes ulcerations and inflammation in the large intestine, causing symptoms that include abdominal pain and the frequent or urgent need for bowel movements.
Approximately 3 million adults in the United States
are affected by inflammatory bowel disease (either Crohn’s disease or ulcerative colitis); and while there have been promising advancements, factors including disease extent, severity, and response to treatment still necessitate treatment plans that are mindfully individualized to each patient.
Chris Arthur first began experiencing symptoms of ulcerative colitis at 19 years old, when he had aspirations of being a professional race car driver. Unfortunately, he was sidelined by the disease shortly after the pursuit of his dream.
He says he went from being a healthy athlete to having his activities severely limited and unable to participate in any sports. He became semi-bedridden for two years, lost 120 pounds and was struggling both physically and emotionally.
He consulted with several doctors,
underwent tests and was prescribed medication, but nothing seemed to help. Finally, after a visit to a gastroenterologist, Chris was starting to make progress and was prescribed new treatments that gave him a new outlook and the confidence that he can still return to a sense of normalcy in his life.
Chris is now on a therapy treatment that has helped to get his disease under control. It’s allowed him to live life on his terms, pursuing a career as a Hollywood stunt man while also working as a racing car instructor. He has a family and is once again pursuing the opportunity to participate in a professional race.
Chris says while ulcerative colitis
can be daunting and demoralizing at times, he wants others who have the disease to know there is help and hope for them, too.
Join me in a recent interview with Chris Arthur as he talked about his inspiring journey, the treatment that helped him resume his life, and how he wants to work to motivate and educate others about the disease.
Also joining him, was Dr. Arthur Kornbluth, a Gastroenterologist and Clinical Professor of Medicine at Mount Sinai School of Medicine in New York, as he outlined more about the disease, discussed the latest treatment options, and provided tips on how to collaborate with your doctor to best manage ulcerative colitis symptoms.
See the entire interview here:
Stunt Performer / Race Car Driver, diagnosed with ulcerative colitis at age 19
When Chris Arthur was 19 years old he began experiencing symptoms of ulcerative colitis, putting his dreams of being a professional race car driver on hold. After years of setbacks and meetings with several doctors, he began working with a gastroenterologist who finally helped him identify a treatment option to make progress in addressing his symptoms.
Chris now has a career as a stunt performer for movies and television, has worked as a race instructor, has been able to have a family, and is reembarking on this racing aspirations. He looks forward to sharing his story with others who may be impacted by inflammatory bowel diseases.
Asher Arthur Kornbluth, M.D.
Clinical Professor of Medicine, Icahn School of Medicine at Mount Sinai, and in Private Practice at New York Gastroenterology Associates
A practicing gastroenterologist in New York City, specializing in the care of patients with the inflammatory bowel diseases Crohn’s disease and ulcerative colitis, Dr. Kornbluth received his medical degree from SUNY Downstate College of Medicine in Brooklyn.
After completing training at the Albert Einstein College of Medicine in the Bronx, serving as both resident and chief resident, he completed his gastroenterology fellowship at Mount Sinai in New York. He has gone on to be a national and international educator, mentor to generations of physicians and widely published medical author, and is repeatedly ranked by his physician peers among America’s top gastroenterologists over the last 30 years.
Interview courtesy: Janssen Biotech, Inc.